Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrates for Osteoporosis Prevention
NCT00252421Phase 3Completed
- Sponsor
- University of Toronto
- Start
- Oct 2005
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Nitroglycerin with Placebo (2 arms). Primary endpoints: Mean headache score associated with each of intermittent nitroglycerin ointment (NTG) and isosorbide mononitrate (ISMO) use at 6 months and Change from baseline in bone mineral density (BMD) at the lumbar spine at 24 months. Started Oct 2005; status: completed.
02
Drugs
nitroglycerin
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00252421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252421.